Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Short-term Investments (2016 - 2022)

Historic Short-term Investments for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $45.8 million.

  • Avadel Pharmaceuticals' Short-term Investments fell 6277.37% to $45.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $45.8 million, marking a year-over-year decrease of 6277.37%. This contributed to the annual value of $106.5 million for FY2021, which is 2883.95% down from last year.
  • According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Short-term Investments is $45.8 million, which was down 6277.37% from $50.0 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Short-term Investments high stood at $157.3 million for Q1 2018, and its period low was $40.0 million during Q1 2020.
  • Its 5-year average for Short-term Investments is $99.0 million, with a median of $106.5 million in 2021.
  • Its Short-term Investments has fluctuated over the past 5 years, first surged by 26471.72% in 2021, then crashed by 6315.94% in 2022.
  • Avadel Pharmaceuticals' Short-term Investments (Quarter) stood at $90.6 million in 2018, then tumbled by 39.97% to $54.4 million in 2019, then surged by 175.23% to $149.7 million in 2020, then dropped by 28.84% to $106.5 million in 2021, then tumbled by 57.04% to $45.8 million in 2022.
  • Its Short-term Investments was $45.8 million in Q3 2022, compared to $50.0 million in Q2 2022 and $62.6 million in Q1 2022.